These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 29316310

  • 21. National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35.
    Nekrasov V, Matsuoka L, Rauf M, Kaur N, Cao S, Groshen S, Alexopoulos SP.
    Am J Transplant; 2016 Oct; 16(10):2912-2924. PubMed ID: 27063579
    [Abstract] [Full Text] [Related]

  • 22. Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study.
    Lee J, Lee JG, Jung I, Joo DJ, Kim SI, Kim MS, Advisory Committee on Improving Liver Allocation.
    Sci Rep; 2019 May 16; 9(1):7495. PubMed ID: 31097768
    [Abstract] [Full Text] [Related]

  • 23. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct 16; 44(8):2283-5. PubMed ID: 23026574
    [Abstract] [Full Text] [Related]

  • 24. Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change.
    Ishaque T, Massie AB, Bowring MG, Haugen CE, Ruck JM, Halpern SE, Waldram MM, Henderson ML, Garonzik Wang JM, Cameron AM, Philosophe B, Ottmann S, Rositch AF, Segev DL.
    Am J Transplant; 2019 Feb 16; 19(2):564-572. PubMed ID: 30312530
    [Abstract] [Full Text] [Related]

  • 25. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Nekrasov V, Matsuoka L, Kaur N, Pita A, Whang G, Cao S, Groshen S, Alexopoulos S.
    Transplantation; 2017 Oct 16; 101(10):2360-2367. PubMed ID: 28319564
    [Abstract] [Full Text] [Related]

  • 26. [Predictors of mortality among liver transplant candidates].
    Erez D, Ben Ari Z, Michowitz R, Mor E.
    Harefuah; 2011 Jan 16; 150(1):16-20, 70, 69. PubMed ID: 21449150
    [Abstract] [Full Text] [Related]

  • 27. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.
    Genda T, Ichida T, Sakisaka S, Sata M, Tanaka E, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y.
    J Gastroenterol; 2014 Feb 16; 49(2):324-31. PubMed ID: 23478939
    [Abstract] [Full Text] [Related]

  • 28. Directed solutions to address differences in access to liver transplantation.
    Ye F, Sheng Q, Feurer ID, Zhao Z, Fan R, Teng J, Ping J, Rega SA, Hanto DW, Shyr Y, Karp SJ.
    Am J Transplant; 2018 Nov 16; 18(11):2670-2678. PubMed ID: 29689125
    [Abstract] [Full Text] [Related]

  • 29. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, Wood NL, Gentry SE, Kwong AJ.
    Gastroenterology; 2021 Dec 16; 161(6):1887-1895.e4. PubMed ID: 34481845
    [Abstract] [Full Text] [Related]

  • 30. Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End-Stage Liver Disease Patients.
    Ross K, Patzer RE, Goldberg DS, Lynch RJ.
    Am J Transplant; 2017 Nov 16; 17(11):2879-2889. PubMed ID: 28695615
    [Abstract] [Full Text] [Related]

  • 31. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Safwan M, Nwagu U, Collins K, Abouljoud M, Nagai S.
    Transplantation; 2019 Oct 16; 103(10):2121-2129. PubMed ID: 30747840
    [Abstract] [Full Text] [Related]

  • 32. MELD-based liver allocation: who is underserved?
    Biggins SW, Bambha K.
    Semin Liver Dis; 2006 Aug 16; 26(3):211-20. PubMed ID: 16850370
    [Abstract] [Full Text] [Related]

  • 33. Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35.
    Chow EK, Massie AB, Luo X, Wickliffe CE, Gentry SE, Cameron AM, Segev DL.
    Am J Transplant; 2017 Feb 16; 17(2):512-518. PubMed ID: 27457221
    [Abstract] [Full Text] [Related]

  • 34. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.
    Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM.
    Am J Transplant; 2008 Feb 16; 8(2):419-25. PubMed ID: 18190658
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Combined heart-liver transplantation in the MELD era: do waitlisted patients require exception status?
    Schaffer JM, Chiu P, Singh SK, Oyer PE, Reitz BA, Mallidi HR.
    Am J Transplant; 2014 Mar 16; 14(3):647-59. PubMed ID: 24517245
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.